增殖细胞核抗原（PCNA）在胃癌中的表达：无预后价值的证据。
Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value.
作者信息
Mangham D C, Rowlands D C, Newbold K M, Reynolds G M, Fielding J W, Hallissey M T
机构信息
Department of Pathology, University of Birmingham.
出版信息
J Clin Pathol. 1994 May;47(5):473-4. doi: 10.1136/jcp.47.5.473.
Abstract
It has been proposed that immunostaining with PC10, a monoclonal antibody against proliferating cell nuclear antigen (PCNA), is of prognostic value in gastric carcinoma. Gastric carcinomas from a series of 90 patients in whom survival data were known have been studied. There was no relation between the degree of PC10 immunostaining assessed semiquantitatively and survival.
摘要
有人提出，用PC10（一种针对增殖细胞核抗原（PCNA）的单克隆抗体）进行免疫染色对胃癌具有预后价值。我们对90例已知生存数据的患者的胃癌进行了研究。半定量评估的PC10免疫染色程度与生存率之间没有关系。
相似文献
1
Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value.
J Clin Pathol. 1994 May;47(5):473-4. doi: 10.1136/jcp.47.5.473.
2
Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.
J Clin Pathol. 1991 Aug;44(8):655-9. doi: 10.1136/jcp.44.8.655.
3
Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.
Pathol Oncol Res. 2000;6(1):59-64. doi: 10.1007/BF03032660.
4
Proliferative activity of gastric cancer assessed by immunostaining for proliferating cell nuclear antigen.
J Surg Oncol. 1993 Nov;54(3):146-51; discussion 151-2. doi: 10.1002/jso.2930540303.
5
Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?
Br J Cancer. 1995 Feb;71(2):357-62. doi: 10.1038/bjc.1995.72.
6
Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis.
Cancer. 1994 Feb 1;73(3):528-33. doi: 10.1002/1097-0142(19940201)73:3<528::aid-cncr2820730306>3.0.co;2-p.
7
[Proliferating cell nuclear antigen (PCNA/cyclin) in gastric carcinoma in relation to its prognosis].
Zhonghua Zhong Liu Za Zhi. 1993 Jan;15(1):34-6.
8
Assessment of proliferating cell nuclear antigen expression in precursor stages of gastric carcinoma using the PC10 antibody to PCNA.
Histopathology. 1993 Apr;22(4):349-54. doi: 10.1111/j.1365-2559.1993.tb00134.x.
9
Cell proliferation in breast carcinoma assessed by a PCNA grading system and its relation to other prognostic variables.
Surg Oncol. 1993;2(1):59-63. doi: 10.1016/0960-7404(93)90045-z.
10
The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer.
Surgery. 1993 Jun;113(6):683-90.
引用本文的文献
1
Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis.
Onco Targets Ther. 2017 Jan 10;10:319-327. doi: 10.2147/OTT.S126551. eCollection 2017.
2
High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
World J Gastroenterol. 2012 Dec 28;18(48):7319-26. doi: 10.3748/wjg.v18.i48.7319.
3
The abundance of Rad51 protein in mouse embryonic stem cells is regulated at multiple levels.
Stem Cell Res. 2012 Sep;9(2):124-34. doi: 10.1016/j.scr.2012.05.004. Epub 2012 May 22.
4
Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.
Pathol Oncol Res. 2000;6(1):59-64. doi: 10.1007/BF03032660.
本文引用的文献
1
The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens.
Histopathology. 1993 Jun;22(6):543-7. doi: 10.1111/j.1365-2559.1993.tb00174.x.
2
Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy.
Cancer. 1993 Apr 15;71(8):2448-53. doi: 10.1002/1097-0142(19930415)71:8<2448::aid-cncr2820710804>3.0.co;2-v.
3
Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.
J Pathol. 1990 Dec;162(4):285-94. doi: 10.1002/path.1711620403.
4
Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form.
J Cell Sci. 1990 May;96 ( Pt 1):121-9. doi: 10.1242/jcs.96.1.121.
5
A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction.
J Pathol. 1991 Oct;165(2):173-8. doi: 10.1002/path.1711650213.
6
Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA).
Histopathology. 1991 Jul;19(1):29-33. doi: 10.1111/j.1365-2559.1991.tb00891.x.
7
Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.
J Clin Pathol. 1991 Aug;44(8):655-9. doi: 10.1136/jcp.44.8.655.
8
The complexities of proliferating cell nuclear antigen.
Histopathology. 1992 Dec;21(6):591-4. doi: 10.1111/j.1365-2559.1992.tb00454.x.
9
Measurement of cell proliferation in gastric carcinoma: comparative analysis of Ki-67 and proliferative cell nuclear antigen (PCNA).
Histochem J. 1992 Feb;24(2):93-101. doi: 10.1007/BF01082445.
10
A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
J Pathol. 1992 Feb;166(2):147-52. doi: 10.1002/path.1711660210.
Zotero 插件